This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2010 Mar 18;464(7287):358-9.

doi: 10.1038/464358a.

Drug discovery: inhibitors that activate

Karen Cichowski, Pasi A Jänne

PMID: 20237552
DOI: 10.1038/464358a

Comment

Drug discovery: inhibitors that activate

Karen Cichowski et al. Nature. 2010.

. 2010 Mar 18;464(7287):358-9.

doi: 10.1038/464358a.

Authors

Karen Cichowski, Pasi A Jänne

PMID: 20237552
DOI: 10.1038/464358a

No abstract available

PubMed Disclaimer

Comment on

RAF inhibitors prime wild-type RAF to activate the MAPK pathway and enhance growth.
Hatzivassiliou G, Song K, Yen I, Brandhuber BJ, Anderson DJ, Alvarado R, Ludlam MJ, Stokoe D, Gloor SL, Vigers G, Morales T, Aliagas I, Liu B, Sideris S, Hoeflich KP, Jaiswal BS, Seshagiri S, Koeppen H, Belvin M, Friedman LS, Malek S. Hatzivassiliou G, et al. Nature. 2010 Mar 18;464(7287):431-5. doi: 10.1038/nature08833. Epub 2010 Feb 3. Nature. 2010. PMID: 20130576
RAF inhibitors transactivate RAF dimers and ERK signalling in cells with wild-type BRAF.
Poulikakos PI, Zhang C, Bollag G, Shokat KM, Rosen N. Poulikakos PI, et al. Nature. 2010 Mar 18;464(7287):427-30. doi: 10.1038/nature08902. Nature. 2010. PMID: 20179705 Free PMC article.

Similar articles

RAF inhibitors prime wild-type RAF to activate the MAPK pathway and enhance growth.
Hatzivassiliou G, Song K, Yen I, Brandhuber BJ, Anderson DJ, Alvarado R, Ludlam MJ, Stokoe D, Gloor SL, Vigers G, Morales T, Aliagas I, Liu B, Sideris S, Hoeflich KP, Jaiswal BS, Seshagiri S, Koeppen H, Belvin M, Friedman LS, Malek S. Hatzivassiliou G, et al. Nature. 2010 Mar 18;464(7287):431-5. doi: 10.1038/nature08833. Epub 2010 Feb 3. Nature. 2010. PMID: 20130576
RAF inhibitors transactivate RAF dimers and ERK signalling in cells with wild-type BRAF.
Poulikakos PI, Zhang C, Bollag G, Shokat KM, Rosen N. Poulikakos PI, et al. Nature. 2010 Mar 18;464(7287):427-30. doi: 10.1038/nature08902. Nature. 2010. PMID: 20179705 Free PMC article.
Drug discovery: How melanomas bypass new therapy.
Solit D, Sawyers CL. Solit D, et al. Nature. 2010 Dec 16;468(7326):902-3. doi: 10.1038/468902a. Nature. 2010. PMID: 21164474 No abstract available.
MEK and RAF inhibitors for BRAF-mutated cancers.
Belden S, Flaherty KT. Belden S, et al. Expert Rev Mol Med. 2012 Oct 12;14:e17. doi: 10.1017/erm.2012.11. Expert Rev Mol Med. 2012. PMID: 23058743 Review.
Resistance to MEK inhibitors: should we co-target upstream?
Poulikakos PI, Solit DB. Poulikakos PI, et al. Sci Signal. 2011 Mar 29;4(166):pe16. doi: 10.1126/scisignal.2001948. Sci Signal. 2011. PMID: 21447797 Review.

See all similar articles

Cited by

PI3K-AKT-mTOR-signaling and beyond: the complex network in gastroenteropancreatic neuroendocrine neoplasms.
Briest F, Grabowski P. Briest F, et al. Theranostics. 2014 Jan 29;4(4):336-65. doi: 10.7150/thno.7851. eCollection 2014. Theranostics. 2014. PMID: 24578720 Free PMC article. Review.
Resistance to chemotherapy and molecularly targeted therapies: rationale for combination therapy in malignant melanoma.
Wu S, Singh RK. Wu S, et al. Curr Mol Med. 2011 Oct;11(7):553-63. doi: 10.2174/156652411800615153. Curr Mol Med. 2011. PMID: 21707515 Free PMC article. Review.
A novel compound which sensitizes BRAF wild-type melanoma cells to vemurafenib in a TRIM16-dependent manner.
Sutton SK, Carter DR, Kim P, Tan O, Arndt GM, Zhang XD, Baell J, Noll BD, Wang S, Kumar N, McArthur GA, Cheung BB, Marshall GM. Sutton SK, et al. Oncotarget. 2016 Aug 9;7(32):52166-52178. doi: 10.18632/oncotarget.10700. Oncotarget. 2016. PMID: 27447557 Free PMC article.
DROIDS 3.0-Detecting Genetic and Drug Class Variant Impact on Conserved Protein Binding Dynamics.
Babbitt GA, Fokoue EP, Evans JR, Diller KI, Adams LE. Babbitt GA, et al. Biophys J. 2020 Feb 4;118(3):541-551. doi: 10.1016/j.bpj.2019.12.008. Epub 2019 Dec 18. Biophys J. 2020. PMID: 31928763 Free PMC article.
Selective CRAF Inhibition Elicits Transactivation.
Morgan CW, Dale IL, Thomas AP, Hunt J, Chin JW. Morgan CW, et al. J Am Chem Soc. 2021 Mar 31;143(12):4600-4606. doi: 10.1021/jacs.0c11958. Epub 2021 Mar 22. J Am Chem Soc. 2021. PMID: 33750116 Free PMC article.

See all "Cited by" articles

References

1. J Clin Oncol. 2008 May 1;26(13):2139-46 - PubMed
1. J Clin Oncol. 2009 Aug 10;27(23):e59-61 - PubMed
1. Arch Dermatol. 1995 Jul;131(7):796-800 - PubMed
1. Nature. 2006 Jan 19;439(7074):358-62 - PubMed
1. Nature. 2010 Mar 18;464(7287):427-30 - PubMed

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Nature Publishing Group
- Ovid Technologies, Inc.
Other Literature Sources
- The Lens - Patent Citations Database